Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases - Concepedia

Concepedia

Publication | Open Access

Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

DOI Full Paper Access

51

Citations

17

References

2003

Year

Yihan Wang, Chester A. Metcalf, William C. Shakespeare, Raji Sundaramoorthi, Terence P. Keenan, Regine S. Bohacek, Marie Rose van Schravendijk, Shiela M. Violette, Surinder S. Narula, David C. Dalgarno,

Bioorganic & Medicinal Chemistry Letters

Medicinal ChemistrySclerostinBone-targeted 2,6,9-Trisubstituted PurinesBone Morphogenic ProteinMedicineSrc Tyrosine KinaseBone MetabolismBone DiseasesBone HomeostasisPharmacologyOsteoporosisOrthopaedic SurgeryDrug Discovery

References

	Year	Citations

Page 1

Page 1